Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer

被引：8
|
作者：
Wang, Yan [1 ]
Lin, Rongjie [1 ,2 ]
Ling, Huan [1 ]
Ke, Yuan [1 ]
Zeng, Yangyang [1 ]
Xiong, Yudi [1 ]
Zhou, Qian [1 ]
Zhou, Fuxiang [1 ,3 ]
Zhou, Yunfeng [1 ,3 ]
机构：
[1] Hubei Key Lab Tumor Biol Behav, Wuhan, Hubei, Peoples R China
[2] Fujian Med Univ, Fujian Canc Hosp, Dept Radiat Oncol, Canc Hosp, Fuzhou, Fujian, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Hubei, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2019年 / 4卷 / 1期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1038/s41392-019-0088-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models
    Hindley, C.
    Biondo, A.
    Brothwood, J.
    Dao, K. H.
    Kandola, N.
    Lyons, J.
    Nakatsuru, Y.
    Smyth, T.
    Wagner, S.
    Wallis, N.
    Hearn, K.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S57 - S57
  • [42] miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer
    Zhu, Xiangyu
    Ma, Si-ping
    Yang, Dongxiang
    Liu, Yanlong
    Wang, Yong-peng
    Lin, Tao
    Li, Yan-xi
    Yang, Shi-hua
    Zhang, Wan-chuan
    Wang, Xin-ling
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (04) : 1969 - 1981
  • [43] Synergistic effect of combined cdk4/6 inhibitor with docetaxel in lung cancer cell lines harboring KRAS mutations
    Son, Kyoung Hwa
    Shin, Jung-Young
    Kim, Jeong-Oh
    Kang, JinHyoung
    CANCER RESEARCH, 2016, 76
  • [44] Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
    Huijberts, Sanne C. F. A.
    van Geel, Robin M. J. M.
    van Brummelen, Emilie M. J.
    Opdam, Frans L.
    Marchetti, Serena
    Steeghs, Neeltje
    Pulleman, Saskia
    Thijssen, Bas
    Rosing, Hilde
    Monkhorst, Kim
    Huitema, Alwin D. R.
    Beijnen, Jos H.
    Bernards, Rene
    Schellens, Jan H. M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 917 - 930
  • [45] Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in KRAS-Mutant Cancer Cells
    Erber, Johanna
    Steiner, Joachim D.
    Isensee, Joerg
    Lobbes, Leonard A.
    Toschka, Andre
    Beleggia, Filippo
    Schmitt, Anna
    Kaiser, Rainer W. J.
    Siedek, Florian
    Persigehl, Thorsten
    Hucho, Tim
    Reinhardt, Hans C.
    CANCER RESEARCH, 2019, 79 (19) : 4855 - 4868
  • [46] A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer
    Jin, Jiaying
    Li, Yijia
    Deng, Feiyang
    Yang, Long
    Lin, Yuxing
    Yang, Canyu
    Dai, Wenbing
    Zhang, Hua
    He, Bing
    Zhang, Qiang
    Wang, Xueqing
    NANO TODAY, 2024, 56
  • [47] Synergistic effect of combined CDK4/6 inhibitor with docetaxel in lung cancer cell lines harboring KRAS mutations
    Hwa, S. Kyoung
    Young, S. Jung
    Oh, K. Jeong
    Young, K. Min
    Hyoung, K. Jin
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S35 - S35
  • [48] Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
    Sanne C. F. A. Huijberts
    Robin M. J. M. van Geel
    Emilie M. J. van Brummelen
    Frans L. Opdam
    Serena Marchetti
    Neeltje Steeghs
    Saskia Pulleman
    Bas Thijssen
    Hilde Rosing
    Kim Monkhorst
    Alwin D. R. Huitema
    Jos H. Beijnen
    René Bernards
    Jan H. M. Schellens
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 917 - 930
  • [49] Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
    Leonard, John P.
    LaCasce, Ann S.
    Smith, Mitchell R.
    Noy, Ariela
    Chirieac, Lucian R.
    Rodig, Scott J.
    Yu, Jian Q.
    Vallabhajosula, Shankar
    Schoder, Heiko
    English, Patricia
    Neuberg, Donna S.
    Martin, Peter
    Millenson, Michael M.
    Ely, Scott A.
    Courtney, Rachel
    Shaik, Naveed
    Wilner, Keith D.
    Randolph, Sophia
    Van den Abbeele, Annick D.
    Chen-Kiang, Selina Y.
    Yap, Jeffrey T.
    Shapiro, Geoffrey I.
    BLOOD, 2012, 119 (20) : 4597 - 4607
  • [50] Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses Kras-mutated non-small cell lung cancer
    Wang, Yu-xiang
    Li, Xian
    Liu, Xue-ling
    Wang, Bo-bo
    Chen, Yi
    Yang, Chun-hao
    Ding, Jian
    Meng, Ling-hua
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 44 - 45
12345